Ontology highlight
ABSTRACT:
INSTRUMENT(S):
ORGANISM(S): Mus Musculus (mouse)
TISSUE(S): Breast Cancer Cell Line
SUBMITTER:
Manfred Heller
LAB HEAD: Sven Rottenberg
PROVIDER: PXD035143 | Pride | 2025-08-21
REPOSITORIES: Pride
| Action | DRS | |||
|---|---|---|---|---|
| 20210119_WCL12_KO3_CD_i01.raw | Raw | |||
| 20210119_WCL12_KO3_CD_i02.raw | Raw | |||
| 20210119_WCL18_KO9_CD_i01.raw | Raw | |||
| 20210119_WCL18_KO9_CD_i02.raw | Raw | |||
| 20210119_WCL2_WT2_CD_i01.raw | Raw |
Items per page: 5 1 - 5 of 130 |

Widmer Carmen Alexandra CA Moyseos Anna A Klebic Ismar I Dettwiler Martina M González-Fernández Martín M Gogola Ewa E Siffert Myriam M Buchs Natasha N Braga-Lagache Sophie S Uldry Anne-Christine AC Jonkers Jos J Heller Manfred M Rottenberg Sven S
Communications biology 20251006 1
The platinum-based drugs cis- and carboplatin, which are crucial for treating cancers with DNA repair defects, like those caused by BRCA1/2 mutations, rely on the volume-regulated anion channel subunits LRRC8A and LRRC8D for about 50% of cellular drug uptake. Yet, the precise mechanisms of how LRRC8A and LRRC8D mediate this function are largely unknown. Here, we identify NAA60, an N-terminal acetyltransferase, which localizes to the Golgi apparatus to affect LRRC8A and LRRC8D function. Our data ...[more]